Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?

Asmar M, Bache M, Knop FK, Madsbad S, Holst JJ.

J Clin Endocrinol Metab. 2010 May;95(5):2367-75. doi: 10.1210/jc.2009-2133. Epub 2010 Mar 1.

PMID:
20194711
2.

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.

Flint A, Raben A, Ersbøll AK, Holst JJ, Astrup A.

Int J Obes Relat Metab Disord. 2001 Jun;25(6):781-92.

PMID:
11439290
3.

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

Näslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rössner S, Hellström PM.

Int J Obes Relat Metab Disord. 1999 Mar;23(3):304-11.

PMID:
10193877
4.

The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.

Lee A, Patrick P, Wishart J, Horowitz M, Morley JE.

Diabetes Obes Metab. 2002 Sep;4(5):329-35.

PMID:
12190996
6.

The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM.

Kong MF, Stubbs TA, King P, Macdonald IA, Lambourne JE, Blackshaw PE, Perkins AC, Tattersall RB.

Diabetologia. 1998 May;41(5):577-83.

PMID:
9628276
7.

New physiological effects of the incretin hormones GLP-1 and GIP.

Asmar M.

Dan Med Bull. 2011 Feb;58(2):B4248. Review.

PMID:
21299928
8.

Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial.

Thazhath SS, Wu T, Bound MJ, Checklin HL, Standfield S, Jones KL, Horowitz M, Rayner CK.

Am J Clin Nutr. 2016 Jan;103(1):66-70. doi: 10.3945/ajcn.115.117440. Epub 2015 Nov 25.

9.

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults.

van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH.

Int J Obes (Lond). 2014 Jun;38(6):784-93. doi: 10.1038/ijo.2013.162. Epub 2013 Sep 3.

10.

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, Schmiegel WH.

Am J Physiol. 1997 Nov;273(5 Pt 1):E981-8.

11.

No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man.

Long SJ, Sutton JA, Amaee WB, Giouvanoudi A, Spyrou NM, Rogers PJ, Morgan LM.

Br J Nutr. 1999 Apr;81(4):273-9.

PMID:
10999014
12.

Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.

Bagger JI, Holst JJ, Hartmann B, Andersen B, Knop FK, Vilsbøll T.

J Clin Endocrinol Metab. 2015 Dec;100(12):4541-52. doi: 10.1210/jc.2015-2335. Epub 2015 Oct 7.

PMID:
26445112
13.
14.

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM.

Kong MF, King P, Macdonald IA, Stubbs TA, Perkins AC, Blackshaw PE, Moyses C, Tattersall RB.

Diabetologia. 1997 Jan;40(1):82-8.

PMID:
9028722
15.

The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.

Frost GS, Brynes AE, Dhillo WS, Bloom SR, McBurney MI.

Eur J Clin Nutr. 2003 Feb;57(2):293-8.

PMID:
12571662
16.

Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes.

Heptulla RA, Rodriguez LM, Mason KJ, Haymond MW.

Pediatr Diabetes. 2008 Dec;9(6):561-6. doi: 10.1111/j.1399-5448.2008.00430.x. Epub 2008 Aug 27.

PMID:
18761650
17.

Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial.

Bottin JH, Swann JR, Cropp E, Chambers ES, Ford HE, Ghatei MA, Frost GS.

Br J Nutr. 2016 Jul;116(2):360-74. doi: 10.1017/S0007114516001872. Epub 2016 May 20.

18.

Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses.

Little TJ, Pilichiewicz AN, Russo A, Phillips L, Jones KL, Nauck MA, Wishart J, Horowitz M, Feinle-Bisset C.

J Clin Endocrinol Metab. 2006 May;91(5):1916-23. Epub 2006 Feb 21.

PMID:
16492694
19.

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.

Näslund E, Gutniak M, Skogar S, Rössner S, Hellström PM.

Am J Clin Nutr. 1998 Sep;68(3):525-30.

PMID:
9734726
20.

Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.

Nauck MA, Kemmeries G, Holst JJ, Meier JJ.

Diabetes. 2011 May;60(5):1561-5. doi: 10.2337/db10-0474. Epub 2011 Mar 23.

Supplemental Content

Support Center